PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 108 filers reported holding PASSAGE BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $125 | -15.0% | 130,188 | +21.9% | 0.01% | -33.3% |
| Q4 2022 | $147 | -99.9% | 106,836 | +25.4% | 0.02% | +28.6% |
| Q3 2022 | $106,000 | -50.0% | 85,196 | -5.0% | 0.01% | -56.2% |
| Q2 2022 | $212,000 | +0.5% | 89,704 | +31.8% | 0.03% | +14.3% |
| Q1 2022 | $211,000 | +43.5% | 68,039 | +194.7% | 0.03% | +55.6% |
| Q4 2021 | $147,000 | -32.9% | 23,086 | +5.0% | 0.02% | -18.2% |
| Q3 2021 | $219,000 | – | 21,979 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $6,844,481 | 14.16% |
| Lynx1 Capital Management LP | 3,355,917 | $4,631,165 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,447,132 | 2.50% |
| BML Capital Management, LLC | 337,467 | $465,704 | 0.44% |
| Frazier Life Sciences Management, L.P. | 3,756,915 | $5,184,543 | 0.32% |
| Orbimed Advisors | 8,931,999 | $12,326,159 | 0.24% |
| Newtyn Management, LLC | 790,000 | $1,090,200 | 0.22% |
| Oasis Management Co Ltd. | 240,000 | $331,200 | 0.07% |
| Rubric Capital Management LP | 822,105 | $1,134,505 | 0.05% |
| Marquette Asset Management, LLC | 67,101 | $92,599 | 0.03% |